Amazon has launched a new weight management program through Amazon One Medical that integrates primary care, pharmacy services and virtual care to support patients using GLP-1 medications.
The program, announced April 21 in a news release, aims to streamline obesity treatment by combining clinical care with medication access and delivery on a single platform.
The GLP-1 Management Program embeds weight loss treatment into a patient’s primary care relationship, allowing clinicians to monitor related conditions such as cardiovascular disease and diabetes while providing ongoing follow-up and treatment adjustments.
Amazon is also expanding access to GLP-1 medications through Amazon Pharmacy, offering oral and injectable options with upfront pricing. Costs start as low as $25 per month with insurance or $149 per month for oral medications and $299 per month for injectables for cash-paying patients, the release said.
Same-day delivery is available in nearly 3,000 cities and is expected to expand to about 4,500 by the end of 2026.
The company is also offering 24/7 telehealth prescription renewals for existing GLP-1 users, starting at $29 for messaging consultations.
Amazon said the program is designed to reduce fragmented care by connecting primary care, pharmacy and virtual services into a single experience for patients managing obesity.
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
